{
    "paper_id": "PMC7163230",
    "metadata": {
        "title": "Does the direct renin inhibitor have a role to play in attenuating\nseverity of the outbreak coronavirus disease 2019 (COVID-19)?",
        "authors": [
            {
                "first": "Cheng-Wei",
                "middle": [],
                "last": "Lin",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Yu-Yao",
                "middle": [],
                "last": "Huang",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Dear Editor",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "The ongoing outbreak of coronavirus disease 2019 (COVID-2019) was caused by the novel\n2019 coronavirus (2019-nCoV), which shares a similar genome sequence with the SARS\ncoronavirus (SARS-CoV).1,2 Like\nSARS-CoV, reports demonstrate that angiotensin-converting enzyme 2 (ACE2) could act as\nthe receptor for 2019-nCoV.1,3\nMoreover, studies have shown that 2019-nCoV binds ACE2 with a higher affinity than the\noriginal SARS virus strain.4",
            "cite_spans": [
                {
                    "start": 192,
                    "end": 193,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 194,
                    "end": 195,
                    "mention": "2",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 315,
                    "end": 316,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 317,
                    "end": 318,
                    "mention": "3",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 433,
                    "end": 434,
                    "mention": "4",
                    "ref_id": "BIBREF9"
                }
            ],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "Renin angiotensin system (RAS) activity regulates the human homeostatic state, and is\nintrinsically high in the lungs, which is rich in ACE and ACE2 and therefore a major\nsite of systemic angiotensin II synthesis.5 ACE2 functions in the RAS as a carboxypeptidase, cleaving angiotensin I to\ngenerate angiotensin 1-9, and cleaving angiotensin II to generate angiotensin\n1-7.6,7 Pulmonary ACE2\nappears to play a role in regulating the balance of circulating\nangiotensin II/angiotensin 1-7 levels. When responding to hypoxia, angiotensin II\ninduces pulmonary vasoconstriction to prevent shunting in patients with pneumonia or\nlung injury; nevertheless, the increased production of angiotensin II in the lungs under\nhypoxia also enhances pulmonary vascular permeability and accelerates subsequent\npulmonary edema.5 In acute respiratory distress syndrome (ARDS), the RAS also plays a major role in\nmaintaining oxygenation. According to ARDS animal models, ACE2 knockout mice presented\nmore severe symptoms compared with wildtype mice, supporting the view that\noverexpression of ACE2 appears protective.8",
            "cite_spans": [
                {
                    "start": 213,
                    "end": 214,
                    "mention": "5",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 372,
                    "end": 373,
                    "mention": "6",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 374,
                    "end": 375,
                    "mention": "7",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 808,
                    "end": 809,
                    "mention": "5",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 1096,
                    "end": 1097,
                    "mention": "8",
                    "ref_id": "BIBREF13"
                }
            ],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "ACE2 is a crucial receptor for SARS-CoV and 2019-nCoV, and binding to ACE2 by CoV spike\nprotein downregulates ACE2 expression. The loss of ACE2 expression results in severe\nacute respiratory failure.9,10\nAT1 receptor (AT1R) mediates angiotensin II-induced vascular permeability and severe\nacute lung injury. Therefore, CoV spike-mediated lung failure is suspected of being\nrescued by inhibition of AT1R from a RAS blockade, such as angiotensin II receptor block\nor angiotensin-converting enzyme inhibitor.9,11 On the other hand, blockade of\nAT1R, with consequent elevation of both angiotensin I and angiotensin II, stimulates\nACE2 activity.6,11 A dilemma is that\nthe RAS blockade could attenuate the severe lung injury induced by CoV infection\nvia inhibition of AT1R, but also increase ACE2 expression and\ntherefore provide more targets for virus binding and replicating. Taking both into\naccount, we hypothesized that a higher-level blockade of RAS might resolve this dilemma.\nThe optimal choice may be the direct renin inhibitor, which could decrease the original\nrenin activity and, consequently, lower angiotensin I and II.10 ACE2 expression would decrease because of low angiotensin I and II activity. Less\nACE2 expression may prevent the body being attacked by 2019-nCoV because of fewer\ntargets for the virus, while the AT1R is still inhibited by low renin activity, with\nadequate lung protection regardless of low ACE2 expression.",
            "cite_spans": [
                {
                    "start": 199,
                    "end": 200,
                    "mention": "9",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 201,
                    "end": 203,
                    "mention": "10",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 505,
                    "end": 506,
                    "mention": "9",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 507,
                    "end": 509,
                    "mention": "11",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 640,
                    "end": 641,
                    "mention": "6",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 642,
                    "end": 644,
                    "mention": "11",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 1127,
                    "end": 1129,
                    "mention": "10",
                    "ref_id": "BIBREF1"
                }
            ],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "For data reported on 2 March 2020 by the World Health Organization (WHO), globally\nregistered COVID-19 cases were 88,948, of which there were 80,174 cases in China, and\nother cases had spread to 64 countries reporting a total of 2069 cases. Very\nsurprisingly, Africa had confirmed only two cases. According to the epidemiology, we\nalso speculate whether the low infection rate in Africa is associated with the\nessentially low renin activity in the population of Africa.12 As we know, the RAS blockade was less effective for hypertension control in the\npopulation of Africa because of their low renin physiology. Additionally, higher\nmortality rates from COVID-19 are noted in aged (14.8% in \u2a7e80 years old) and male (2.8%\nin male and 1.7% in female, respectively) patients.13 Regarding RAS activity, aging is associated with activation of RAS,14 and testosterone in males is thought to increase renin levels.15",
            "cite_spans": [
                {
                    "start": 469,
                    "end": 471,
                    "mention": "12",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 772,
                    "end": 774,
                    "mention": "13",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 842,
                    "end": 844,
                    "mention": "14",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 907,
                    "end": 909,
                    "mention": "15",
                    "ref_id": "BIBREF6"
                }
            ],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "In conclusion, we hypothesize that the direct renin inhibitor may have a potential role\nin both attenuating the disease severity of COVID-19 infection via the\nblockade of RAS and lessening the target for the virus by downregulating ACE2\nexpression. Certainly, this speculation needs further precise investigation to be\nvalidated.",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        }
    ],
    "ref_entries": {},
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Genomic characterisation and\nepidemiology of 2019 novel coronavirus: implications for virus origins and\nreceptor binding",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "395",
            "issn": "",
            "pages": "565-574",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "Three key\nproteases\u2013angiotensin-I-converting enzyme (ACE), ACE2 and renin\u2013within and\nbeyond the renin-angiotensin system",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Guang",
                    "suffix": ""
                },
                {
                    "first": "RD",
                    "middle": [],
                    "last": "Phillips",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Arch Cardiovasc\nDis",
            "volume": "105",
            "issn": "",
            "pages": "373-385",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Angiotensin-converting enzyme 2 and\nangiotensin-(1\u20137): an evolving story in cardiovascular\nregulation",
            "authors": [
                {
                    "first": "CM",
                    "middle": [],
                    "last": "Ferrario",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Hypertension",
            "volume": "47",
            "issn": "",
            "pages": "515-521",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "Why is plasma renin activity lower in\npopulations of African origin?",
            "authors": [
                {
                    "first": "GA",
                    "middle": [],
                    "last": "Sagnella",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "J Hum Hypertens",
            "volume": "15",
            "issn": "",
            "pages": "17-25",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "The epidemiological characteristics of an\noutbreak of 2019 novel coronavirus diseases (COVID-19) in\nChina",
            "authors": [],
            "year": 2020,
            "venue": "Zhonghua Liu Xing Bing Xue Za Zhi",
            "volume": "41",
            "issn": "",
            "pages": "145-151",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "Aging and the renin-angiotensin\nsystem",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Conti",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Cassis",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Benigni",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Hypertension",
            "volume": "60",
            "issn": "",
            "pages": "878-883",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "Gender and the renin-angiotensin-aldosterone\nsystem",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Komukai",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Mochizuki",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Yoshimura",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Fundam Clin Pharmacol",
            "volume": "24",
            "issn": "",
            "pages": "687-698",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "Evolution of the novel\ncoronavirus from the ongoing Wuhan outbreak and modeling of its spike\nprotein for risk of human transmission",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Sci China\nLife Sci",
            "volume": "63",
            "issn": "",
            "pages": "457-460",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "A pneumonia outbreak\nassociated with a new coronavirus of probable bat origin",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "XL",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "XG",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Nature",
            "volume": "579",
            "issn": "",
            "pages": "270-273",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "Cryo-EM structure of the\n2019-nCoV spike in the prefusion conformation",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Wrapp",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "KS",
                    "middle": [],
                    "last": "Corbett",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Science",
            "volume": "367",
            "issn": "",
            "pages": "1260-1263",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF10": {
            "title": "Angiotensin-converting enzyme 2 (ACE2) is a key\nmodulator of the renin angiotensin system in health and\ndisease",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Tikellis",
                    "suffix": ""
                },
                {
                    "first": "MC",
                    "middle": [],
                    "last": "Thomas",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Int J Pept",
            "volume": "2012",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF11": {
            "title": "Renin-angiotensin system\nrevisited",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Fyhrquist",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Saijonmaa",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "J Intern Med",
            "volume": "264",
            "issn": "",
            "pages": "224-236",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF12": {
            "title": "Role of the ACE2/angiotensin\n1\u20137 axis of the renin-angiotensin system in heart failure",
            "authors": [
                {
                    "first": "VB",
                    "middle": [],
                    "last": "Patel",
                    "suffix": ""
                },
                {
                    "first": "JC",
                    "middle": [],
                    "last": "Zhong",
                    "suffix": ""
                },
                {
                    "first": "MB",
                    "middle": [],
                    "last": "Grant",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Circ Res",
            "volume": "118",
            "issn": "",
            "pages": "1313-1326",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF13": {
            "title": "Angiotensin-converting\nenzyme 2 protects from severe acute lung failure",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Imai",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Kuba",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Rao",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Nature",
            "volume": "436",
            "issn": "",
            "pages": "112-116",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF14": {
            "title": "A crucial role of\nangiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung\ninjury",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Kuba",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Imai",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Rao",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Nat Med",
            "volume": "11",
            "issn": "",
            "pages": "875-879",
            "other_ids": {
                "DOI": []
            }
        }
    }
}